Edition:
United States

Teva Pharmaceutical Industries Ltd (TEVA.TA)

TEVA.TA on Tel Aviv Stock Exchange

11,730.00ILa
27 Mar 2017
Change (% chg)

-120.00 (-1.01%)
Prev Close
11,850.00
Open
11,800.00
Day's High
11,810.00
Day's Low
11,640.00
Volume
535,117
Avg. Vol
647,394
52-wk High
21,770.00
52-wk Low
11,640.00

TEVA.TA

Chart for TEVA.TA

About

Teva Pharmaceutical Industries Limited is a pharmaceutical company. The Company is engaged in developing, producing and marketing generic medicines and a portfolio of specialty medicines. The Company operates through two segments: Generic medicines and Specialty medicines. The Company develops, manufactures and sells generic... (more)

Overall

Beta: 1.04
Market Cap(Mil.): ₪121,567.90
Shares Outstanding(Mil.): 1,014.36
Dividend: 127.43
Yield (%): 4.30

Financials

  TEVA.TA Industry Sector
P/E (TTM): 213.10 29.17 29.94
EPS (TTM): 0.56 -- --
ROI: 0.53 13.48 13.01
ROE: 0.24 14.39 14.16

Teva Pharm says media reports of up to 6,000 layoffs incorrect

JERUSALEM Teva Pharmaceutical Industries' plans to end unprofitable activities and freeze recruitment, but said Israeli media reports of up to 6,000 layoffs were incorrect.

Mar 23 2017

Teva Pharm says media reports of up to 6,000 layoffs incorrect

JERUSALEM Teva Pharmaceutical Industries' plans to end unprofitable activities and freeze recruitment, but said Israeli media reports of up to 6,000 layoffs were incorrect.

Mar 23 2017

UPDATE 1-Teva Pharm says media reports of up to 6,000 layoffs incorrect

JERUSALEM, March 23 Teva Pharmaceutical Industries' plans to end unprofitable activities and freeze recruitment, but said Israeli media reports of up to 6,000 layoffs were incorrect.

Mar 23 2017

Teva Pharm may fire 6,000 workers -Israeli media report

JERUSALEM, March 23 Teva Pharmaceutical Industries may fire as many as 6,000 workers worldwide as part of a multi-year efficiency plan, Israel's Calcalist news website reported on Thursday.

Mar 23 2017

BRIEF-OncBioMune announces term sheet to acquire Norepinefrine from Teva Pharmaceuticals in Mexico

* OncBioMune announces term sheet to acquire Norepinefrine from Teva Pharmaceuticals in Mexico

Mar 20 2017

Teva Pharm sells shares in Gamida Cell, raises stake in Clal Biotech

* Teva Pharmaceutical Industries has agreed to sell a small stake in Israel-based Gamida Cell and in return will increase its holdings in Clal Biotechnology, the companies said on Sunday.

Mar 05 2017

BRIEF-Teva says FDA granted priority review for SD-809 for treatment of tardive dyskinesia

* Teva Pharmaceutical Industries Ltd - FDA has assigned a prescription drug user fee act (PDUFA) goal date of August 30, 2017.

Feb 28 2017

Teva settles 'vast majority' of lawsuits over generic Reglan

Teva Pharmaceutical Industries Ltd has agreed to settle the "vast majority" of the roughly 4,000 lawsuits it faced over its generic version of the heartburn drug Reglan, which has been linked to a serious neurological disorder.

Feb 17 2017

Marcato's McGuire criticizes Deckers' retail expansion: CNBC

NEW YORK Mick McGuire, founder of activist hedge fund Marcato Capital Management, told CNBC on Monday that Deckers Outdoor Corp had erred by investing significantly in physical retail stores.

Feb 13 2017

UPDATE 1-Marcato's McGuire criticizes Deckers' retail expansion -CNBC

NEW YORK, Feb 13 Mick McGuire, founder of activist hedge fund Marcato Capital Management, told CNBC on Monday that Deckers Outdoor Corp had erred by investing significantly in physical retail stores.

Feb 13 2017

More From Around the Web

Earnings vs. Estimates